Sasko D Stojanovski
Overview
Explore the profile of Sasko D Stojanovski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farooq O, Memon Z, Stojanovski S, Faden H
Pediatr Neurol
. 2011 Mar;
44(4):311-3.
PMID: 21397177
We report a child who developed agitation and choreoathetoid movements with azithromycin therapy on 2 separate occasions. In both instances, the symptoms resolved when the antibiotic was discontinued. By means...
2.
Stojanovski S, Rasu R, Balkrishnan R, Nahata M
Sleep
. 2007 Aug;
30(8):1013-7.
PMID: 17702271
Objectives: This study examined trends in physician-prescribing of medications for children with sleep difficulties in outpatient settings in the US. Additionally, we explored the incidence of physician prescribing patterns of...
3.
Stojanovski S, Baker S, Casavant M, Hayes J, Robinson R, Nahata M
Pediatr Emerg Care
. 2007 Aug;
23(7):465-8.
PMID: 17666928
Background: Diphenhydramine is frequently used in children, but the consequences of single unintended dose exposures in young children are unknown. Methods: We evaluated 2000-2001 American Association of Poison Control Centers-Toxic...
4.
Stojanovski S, Casavant M, Mousa H, Baker P, Nahata M
Clin Toxicol (Phila)
. 2007 Mar;
45(1):51-5.
PMID: 17357382
Objective: To report a case of hepatitis associated with atomoxetine hydrochloride use and to describe the previously-unpublished severe cases of this syndrome. Case Summary: An eight-year-old female with attention deficient...
5.
Stojanovski S, Robinson R, Baker S, Casavant M, Hayes J, Nahata M
Clin Toxicol (Phila)
. 2006 Jun;
44(3):243-7.
PMID: 16749540
Background: Atomoxetine hydrochloride, a selective norepinephrine reuptake inhibitor was FDA approved for patients with attention-deficit/hyperactivity disorder. Little is known about adverse drug reactions of atomoxetine following an overdose among children....